Yüklüyor......
In vivo delivery of siRNA targeting vasohibin‐2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer
Vasohibin‐2 (VASH2) is a homolog of vasohibin‐1 and exhibits pro‐angiogenic activity. We recently reported that VASH2 is expressed in certain ovarian cancers and promotes tumor growth through angiogenesis. To further demonstrate the effectiveness of molecular targeting of VASH2 for anticancer treatm...
Kaydedildi:
| Yayımlandı: | Cancer Sci |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7654253/ https://ncbi.nlm.nih.gov/pubmed/24118388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12297 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|